Literature DB >> 9031275

Distribution of the cellular uptake of phosphorothioate oligodeoxynucleotides in the rat kidney in vivo.

M A Carome1, Y H Kang, E M Bohen, D E Nicholson, F E Carr, L C Kiandoli, S E Brummel, C M Yuan.   

Abstract

Previous animal studies have demonstrated that following systemic administration phosphorothioate oligodeoxynucleotides (S-ODNs) are primarily excreted by the kidneys and that renal tissue levels of S-ODNs exceed that of other organs. Thus, the kidney may be an ideal target organ for application of antisense S-ODNs in vivo. We examined which cells within the rat kidney have uptake of radiolabeled S-ODNs following intravenous infusion. A 20-base 35S-ODN was infused into 6 adult male Wistar rats. Three animals each were sacrificed 30 min and 4 h after infusion. The kidneys were then removed, fixed, and tissue autoradiography was performed. Similar results were obtained in both groups. The highest level of radioactivity was seen within the proximal tubules. Lower levels of activity were seen within the glomerulus, the parietal epithelial cells of Bowman's space, and distal tubular cells. Very weak activity was also detected within the cells of the loop of Henle and the medullary collecting ducts. These results demonstrated that within the kidney S-ODNs were taken up primarily by proximal tubular cells, with much lower uptake by cells in other segments of the nephron.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9031275     DOI: 10.1159/000189504

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney.

Authors:  Jaklien C Leemans; Geurt Stokman; Nike Claessen; Kasper M Rouschop; Gwendoline J D Teske; Carsten J Kirschning; Shizuo Akira; Tom van der Poll; Jan J Weening; Sandrine Florquin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 2.  Biological barriers to therapy with antisense and siRNA oligonucleotides.

Authors:  R Juliano; J Bauman; H Kang; X Ming
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

Review 3.  Renal gene transfer: nonviral approaches.

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Mol Biotechnol       Date:  2003-07       Impact factor: 2.860

4.  Polysome shift assay for direct measurement of miRNA inhibition by anti-miRNA drugs.

Authors:  John R Androsavich; Daniel J Sobczynski; Xueqing Liu; Shweta Pandya; Vivek Kaimal; Tate Owen; Kai Liu; Deidre A MacKenna; B Nelson Chau
Journal:  Nucleic Acids Res       Date:  2015-09-17       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.